Literature DB >> 35611163

OTUB2 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells by PJA1 Deubiquitylation.

Gang Hu1, Jianwu Yang1, Hongwen Zhang1, Zhen Huang1, Heming Yang1.   

Abstract

Introduction: Recent studies have revealed that several deubiquitinating enzymes (DUBs) play important roles in hepatocellular carcinoma (HCC) progression, but the roles of Otubain 2 (OTUB2) in HCC remain obscure.
Methods: In this study, we investigated the expression of OTUB2 in HCC based on clinical samples and a public online database (ENCORI), and its roles and working mechanisms were further explored by in vitro experiments.
Results: It was found that the expression of OTUB2 was significantly up-regulated in HCC tissues, and correlated with poor prognosis of HCC patients. Functionally, the overexpression of OTUB2 could promote malignant proliferation and metastasis of HCC cells, while knockdown of OTUB2 exerted the opposite results. Using two bioinformatics tools, PJA1 was identified as a potential gene regulated by OTUB2. Mechanistically, it was found that OTUB2 promoted the stabilization of PJA1 by deubiquitylation, based on immunoprecipitation (IP) and cycloheximide (CHX) assays. Moreover, the suppressive effects of OTUB2 depletion on the malignant phenotypes of HCC cells could be reversed by overexpressing PJA1.
Conclusion: In conclusion, our study indicated that OTUB2 could promote the malignant proliferation and migration of HCC cells by increasing the stability of PJA1 via deubiquitylation.
© The Author(s) under exclusive licence to Biomedical Engineering Society 2022.

Entities:  

Keywords:  Deubiquitylation; Hepatocellular carcinoma; Otubain 2; PJA1

Year:  2022        PMID: 35611163      PMCID: PMC9124278          DOI: 10.1007/s12195-022-00720-4

Source DB:  PubMed          Journal:  Cell Mol Bioeng        ISSN: 1865-5025            Impact factor:   3.337


  38 in total

1.  Crystal structure of human otubain 2.

Authors:  Max H Nanao; Sergey O Tcherniuk; Jadwiga Chroboczek; Otto Dideberg; Andréa Dessen; Maxim Y Balakirev
Journal:  EMBO Rep       Date:  2004-07-16       Impact factor: 8.807

Review 2.  The demographics of the ubiquitin system.

Authors:  Michael J Clague; Claire Heride; Sylvie Urbé
Journal:  Trends Cell Biol       Date:  2015-04-21       Impact factor: 20.808

3.  Loss of the tumor suppressor BAP1 causes myeloid transformation.

Authors:  Anwesha Dey; Dhaya Seshasayee; Rajkumar Noubade; Dorothy M French; Jinfeng Liu; Mira S Chaurushiya; Donald S Kirkpatrick; Victoria C Pham; Jennie R Lill; Corey E Bakalarski; Jiansheng Wu; Lilian Phu; Paula Katavolos; Lindsay M LaFave; Omar Abdel-Wahab; Zora Modrusan; Somasekar Seshagiri; Ken Dong; Zhonghua Lin; Mercedesz Balazs; Rowena Suriben; Kim Newton; Sarah Hymowitz; Guillermo Garcia-Manero; Flavius Martin; Ross L Levine; Vishva M Dixit
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

4.  Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.

Authors:  Jian Chen; Abhisek Mitra; Shulin Li; Shumei Song; Bao-Ngoc Nguyen; Jiun-Sheng Chen; Ji-Hyun Shin; Nancy R Gough; Paul Lin; Vincent Obias; Aiwu Ruth He; Zhixing Yao; Tathiane M Malta; Houtan Noushmehr; Patricia S Latham; Xiaoping Su; Asif Rashid; Bibhuti Mishra; Ray-Chang Wu; Lopa Mishra
Journal:  Cancer Res       Date:  2020-03-03       Impact factor: 12.701

5.  The stability and oncogenic function of LIN28A are regulated by USP28.

Authors:  Saba Haq; Soumyadip Das; Dong-Ho Kim; Arun Pandian Chandrasekaran; Seok-Ho Hong; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-12-10       Impact factor: 5.187

6.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.

Authors:  Zefang Tang; Chenwei Li; Boxi Kang; Ge Gao; Cheng Li; Zemin Zhang
Journal:  Nucleic Acids Res       Date:  2017-07-03       Impact factor: 16.971

Review 7.  Deubiquitylating enzymes and drug discovery: emerging opportunities.

Authors:  Jeanine A Harrigan; Xavier Jacq; Niall M Martin; Stephen P Jackson
Journal:  Nat Rev Drug Discov       Date:  2017-09-29       Impact factor: 84.694

8.  Dysregulated PJA1-TGF-β signaling in cancer stem cell-associated liver cancers.

Authors:  Jian Chen; Julian A Gingold
Journal:  Oncoscience       Date:  2020-11-30

Review 9.  Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics.

Authors:  Ainsley Mike Antao; Apoorvi Tyagi; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639

10.  The Deubiquitinating Enzyme Inhibitor PR-619 Enhances the Cytotoxicity of Cisplatin via the Suppression of Anti-Apoptotic Bcl-2 Protein: In Vitro and In Vivo Study.

Authors:  Kuan-Lin Kuo; Shing-Hwa Liu; Wei-Chou Lin; Po-Ming Chow; Yu-Wei Chang; Shao-Ping Yang; Chung-Sheng Shi; Chen-Hsun Hsu; Shih-Ming Liao; Hong-Chiang Chang; Kuo-How Huang
Journal:  Cells       Date:  2019-10-17       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.